Novo Nordisk is the parent company of a group engaged in the development, production and marketing of pharmaceuticals, biological solutions to industrial problems vitamins, dietary supplements and digestive aids. Co. operates on a worldwide basis in two business segments: Diabetes care: discovery, development, manufacturing and marketing of products within the areas of insulin and delivery systems and oral antidiabetic products OAD . Biopharmaceuticals: discovery, development, manufacturing and marketing of products within the therapy areas haemostasis management NovoSeven R RT , growth hormone therapy, hormone replacement therapy and other products.
Quote | Novo Nordisk A/S (NYSE:NVO)
Last: | $128.05 |
---|---|
Change Percent: | 0.83% |
Open: | $128.33 |
Close: | $128.05 |
High: | $128.62 |
Low: | $127.29 |
Volume: | 3,931,650 |
Last Trade Date Time: | 03/27/2024 03:00:00 am |
News | Novo Nordisk A/S (NYSE:NVO)
2024-03-27 19:50:00 ET Summary Positive results achieved from phase 2 MOMENTUM study, whereby patients not only achieved significant weight loss over a 48-week period with pemvidutide but also had lean mass preservation. It is said that the GLP-1 market could exceed $100 billion b...
2024-03-27 17:02:39 ET More on Novo Nordisk Shaping The Future Of Obesity Treatment: GLP-1 Agonists At The Forefront Novo Nordisk: My 'Hold' Thesis For 2024 - The Premium Must Be Justified Novo Nordisk, A Very Healthy Pharma Stalwart Amazon reportedly leaning...
Message Board Posts | Novo Nordisk A/S (NYSE:NVO)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $NVO News Article - Got $5,000? 2 Unstoppable Stocks to Buy and Hold Forever | whytestocks | investorshangout | 04/20/2023 12:45:49 PM |
whytestocks: $NVO News Article - Why Wegovy and Ozempic Could Be Cash Cows for Novo Nordisk | whytestocks | investorshangout | 04/12/2023 3:45:45 PM |
whytestocks: $NVO News Article - Which Healthcare Company Will Be the First to Get to a $1 Trillion | whytestocks | investorshangout | 04/12/2023 3:40:47 PM |
whytestocks: $NVO News Article - 2 Stocks That Could Be Red-Hot Buys in 2023 | whytestocks | investorshangout | 12/14/2022 7:50:48 PM |
whytestocks: $NVO News Article - Novo Nordisk (NVO) Q1 2022 Earnings Call Transcript | whytestocks | investorshangout | 04/29/2022 4:45:50 PM |
News, Short Squeeze, Breakout and More Instantly...
Novo Nordisk A/S Company Name:
NVO Stock Symbol:
NYSE Market:
Monday, Biohaven’s (NYSE:BHVN) CEO, Vlad Coric, joined CNBC Fast Money to discuss the weight loss drug wars and the company...
2024-03-26 10:35:00 ET On March 18, Novo Nordisk (NYSE: NVO) and Nvidia (NASDAQ: NVDA) announced a major new collaboration, an artificial intelligence (AI) project that's already making waves in biopharma. In short, Nvidia is going to be building the pharma company a brand-n...
2024-03-26 05:51:00 ET Some investors might remember the obesity drugs developed by Arena Pharmaceuticals and Vivus Pharmaceuticals several years ago. They'll probably also recall that the initial euphoria over those drugs quickly faded. This time it's different. The commercial success ...